D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRTL
701
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $28.9M | 0.03% |
2,970,000
| – | – |
|
702
CALL
Mettler-Toledo International
MTD
$26.8B
| $28.8M | 0.03% |
21,000
-2,400
| -10% | -$3.46M |
|
|
FOLD
703
DELISTED
Amicus Therapeutics
FOLD
| $28.8M | 0.03% |
3,044,438
+279,142
| +10% | +$2.62M |
|
|
HCVI
704
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $28.8M | 0.03% |
2,970,000
| – | – |
|
|
GRMN
705
Garmin
GRMN
$46.9B
| $28.8M | 0.03% |
242,779
+113,552
| +88% | +$13.7M |
|
706
Pebblebrook Hotel Trust
PEB
$2.16B
| $28.7M | 0.03% |
1,174,000
-8,280
| -0.7% | -$190K |
|
|
HBI
707
DELISTED
Hanesbrands
HBI
| $28.7M | 0.03% |
1,927,943
-4,984
| -0.3% | -$78.4K |
|
708
Liberty Global Class C
LBTYK
$3.27B
| $28.6M | 0.03% |
1,104,845
+397,937
| +56% | +$10.6M |
|
709
PUT
Cenovus Energy
CVE
$54.6B
| $28.6M | 0.03% |
1,714,800
+1,505,600
| +720% | +$22.8M |
|
710
SiteOne Landscape Supply
SITE
$4.43B
| $28.6M | 0.03% |
176,626
-77,047
| -30% | -$14M |
|
711
PUT
NextEra Energy
NEE
$187B
| $28.6M | 0.03% |
337,100
+267,000
| +381% | +$21.4M |
|
712
Exelixis
EXEL
$13.9B
| $28.5M | 0.03% |
1,257,421
-533,558
| -30% | -$10.4M |
|
713
PUT
CVS Health
CVS
$137B
| $28.5M | 0.03% |
281,500
-530,700
| -65% | -$55.8M |
|
|
HZNP
714
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $28.5M | 0.03% |
270,774
+124,881
| +86% | +$12.2M |
|
715
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $28.5M | 0.03% |
291,119
+272,099
| +1,431% | +$27.6M |
|
716
Applovin
APP
$132B
| $28.4M | 0.03% |
516,187
+170,420
| +49% | +$10.8M |
|
717
CALL
NIO
NIO
$11.3B
| $28.4M | 0.03% |
1,347,700
-233,900
| -15% | -$5.51M |
|
718
AerCap
AER
$23.9B
| $28.4M | 0.03% |
563,929
+484,966
| +614% | +$29.1M |
|
719
CALL
Enphase Energy
ENPH
$4.84B
| $28.3M | 0.03% |
140,300
-12,100
| -8% | -$1.9M |
|
720
NXP Semiconductors
NXPI
$68B
| $28.3M | 0.03% |
152,872
+151,467
| +10,781% | +$29.9M |
|
721
CALL
Enbridge
ENB
$124B
| $28.3M | 0.03% |
613,900
+383,900
| +167% | +$16.4M |
|
722
PUT
JD.com
JD
$40.8B
| $28.3M | 0.03% |
488,200
-51,800
| -10% | -$3.52M |
|
723
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
| $28.2M | 0.03% |
+80,000
| New | +$25.9M |
|
724
MGM Resorts International
MGM
$11.7B
| $28.1M | 0.03% |
670,888
-174,586
| -21% | -$7.51M |
|
725
CALL
UnitedHealth
UNH
$382B
| $28.1M | 0.03% |
55,100
-124,400
| -69% | -$60M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.